Global SIP Bioreactor 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI05255033

Publication Date:

May 13, 2025

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global SIP Bioreactor market size is predicted to grow from US$ 903 million in 2025 to US$ 1319 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.
An SIP Bioreactor, which stands for Sterile In-Place Bioreactor, is a specialized type of bioreactor designed with the capability to undergo Sterile In-Place (SIP) cleaning and sterilization processes. This technology allows for the bioreactor to be cleaned and sterilized without being dismantled, significantly reducing the risk of contamination and ensuring the sterility of the process. SIP bioreactors are widely used in the biopharmaceutical industry for the production of therapeutic proteins, vaccines, and other biological products. They offer a reliable and efficient means of maintaining sterile conditions throughout the fermentation process, thereby enhancing the quality and safety of the final product. Additionally, the automated nature of SIP processes helps to streamline production workflows and minimize downtime.
United States market for SIP Bioreactor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for SIP Bioreactor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for SIP Bioreactor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key SIP Bioreactor players cover Cytiva, Merck, Sartorius, Getinge, Corning, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪IP Bioreactor Industry Forecast鈥� looks at past sales and reviews total world SIP Bioreactor sales in 2024, providing a comprehensive analysis by region and market sector of projected SIP Bioreactor sales for 2025 through 2031. With SIP Bioreactor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SIP Bioreactor industry.
This Insight Report provides a comprehensive analysis of the global SIP Bioreactor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on SIP Bioreactor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global SIP Bioreactor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SIP Bioreactor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SIP Bioreactor.
This report presents a comprehensive overview, market shares, and growth opportunities of SIP Bioreactor market by product type, application, key players and key regions and countries.
Segmentation by Type:
Long-Lasting
Single-Use
Segmentation by Application:
Biopharmaceutical
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cytiva
Merck
Sartorius
Getinge
Corning
Danaher Corporation
Eppendorf AG
Esco Lifesciences Group
Infors AG
KNIKBIO
LAMBDA
Solaris Biotech

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global SIP Bioreactor 麻豆原创 Size (2020-2031)
2.1.2 SIP Bioreactor 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for SIP Bioreactor by Country/Region (2020, 2024 & 2031)
2.2 SIP Bioreactor Segment by Type
2.2.1 Long-Lasting
2.2.2 Single-Use
2.3 SIP Bioreactor 麻豆原创 Size by Type
2.3.1 SIP Bioreactor 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global SIP Bioreactor 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 SIP Bioreactor Segment by Application
2.4.1 Biopharmaceutical
2.4.2 Scientific Research
2.4.3 Others
2.5 SIP Bioreactor 麻豆原创 Size by Application
2.5.1 SIP Bioreactor 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global SIP Bioreactor 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 SIP Bioreactor 麻豆原创 Size by Player
3.1 SIP Bioreactor 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global SIP Bioreactor Revenue by Player (2020-2025)
3.1.2 Global SIP Bioreactor Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global SIP Bioreactor Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SIP Bioreactor by Region
4.1 SIP Bioreactor 麻豆原创 Size by Region (2020-2025)
4.2 Global SIP Bioreactor Annual Revenue by Country/Region (2020-2025)
4.3 Americas SIP Bioreactor 麻豆原创 Size Growth (2020-2025)
4.4 APAC SIP Bioreactor 麻豆原创 Size Growth (2020-2025)
4.5 Europe SIP Bioreactor 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa SIP Bioreactor 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas SIP Bioreactor 麻豆原创 Size by Country (2020-2025)
5.2 Americas SIP Bioreactor 麻豆原创 Size by Type (2020-2025)
5.3 Americas SIP Bioreactor 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SIP Bioreactor 麻豆原创 Size by Region (2020-2025)
6.2 APAC SIP Bioreactor 麻豆原创 Size by Type (2020-2025)
6.3 APAC SIP Bioreactor 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe SIP Bioreactor 麻豆原创 Size by Country (2020-2025)
7.2 Europe SIP Bioreactor 麻豆原创 Size by Type (2020-2025)
7.3 Europe SIP Bioreactor 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa SIP Bioreactor by Region (2020-2025)
8.2 Middle East & Africa SIP Bioreactor 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa SIP Bioreactor 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global SIP Bioreactor 麻豆原创 Forecast
10.1 Global SIP Bioreactor Forecast by Region (2026-2031)
10.1.1 Global SIP Bioreactor Forecast by Region (2026-2031)
10.1.2 Americas SIP Bioreactor Forecast
10.1.3 APAC SIP Bioreactor Forecast
10.1.4 Europe SIP Bioreactor Forecast
10.1.5 Middle East & Africa SIP Bioreactor Forecast
10.2 Americas SIP Bioreactor Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 SIP Bioreactor Forecast
10.2.2 Canada 麻豆原创 SIP Bioreactor Forecast
10.2.3 Mexico 麻豆原创 SIP Bioreactor Forecast
10.2.4 Brazil 麻豆原创 SIP Bioreactor Forecast
10.3 APAC SIP Bioreactor Forecast by Region (2026-2031)
10.3.1 China SIP Bioreactor 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 SIP Bioreactor Forecast
10.3.3 Korea 麻豆原创 SIP Bioreactor Forecast
10.3.4 Southeast Asia 麻豆原创 SIP Bioreactor Forecast
10.3.5 India 麻豆原创 SIP Bioreactor Forecast
10.3.6 Australia 麻豆原创 SIP Bioreactor Forecast
10.4 Europe SIP Bioreactor Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 SIP Bioreactor Forecast
10.4.2 France 麻豆原创 SIP Bioreactor Forecast
10.4.3 UK 麻豆原创 SIP Bioreactor Forecast
10.4.4 Italy 麻豆原创 SIP Bioreactor Forecast
10.4.5 Russia 麻豆原创 SIP Bioreactor Forecast
10.5 Middle East & Africa SIP Bioreactor Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 SIP Bioreactor Forecast
10.5.2 South Africa 麻豆原创 SIP Bioreactor Forecast
10.5.3 Israel 麻豆原创 SIP Bioreactor Forecast
10.5.4 Turkey 麻豆原创 SIP Bioreactor Forecast
10.6 Global SIP Bioreactor Forecast by Type (2026-2031)
10.7 Global SIP Bioreactor Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 SIP Bioreactor Forecast
11 Key Players Analysis
11.1 Cytiva
11.1.1 Cytiva Company Information
11.1.2 Cytiva SIP Bioreactor Product Offered
11.1.3 Cytiva SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Cytiva Main Business Overview
11.1.5 Cytiva Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck SIP Bioreactor Product Offered
11.2.3 Merck SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Sartorius
11.3.1 Sartorius Company Information
11.3.2 Sartorius SIP Bioreactor Product Offered
11.3.3 Sartorius SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Sartorius Main Business Overview
11.3.5 Sartorius Latest Developments
11.4 Getinge
11.4.1 Getinge Company Information
11.4.2 Getinge SIP Bioreactor Product Offered
11.4.3 Getinge SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Getinge Main Business Overview
11.4.5 Getinge Latest Developments
11.5 Corning
11.5.1 Corning Company Information
11.5.2 Corning SIP Bioreactor Product Offered
11.5.3 Corning SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Corning Main Business Overview
11.5.5 Corning Latest Developments
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Information
11.6.2 Danaher Corporation SIP Bioreactor Product Offered
11.6.3 Danaher Corporation SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Danaher Corporation Main Business Overview
11.6.5 Danaher Corporation Latest Developments
11.7 Eppendorf AG
11.7.1 Eppendorf AG Company Information
11.7.2 Eppendorf AG SIP Bioreactor Product Offered
11.7.3 Eppendorf AG SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Eppendorf AG Main Business Overview
11.7.5 Eppendorf AG Latest Developments
11.8 Esco Lifesciences Group
11.8.1 Esco Lifesciences Group Company Information
11.8.2 Esco Lifesciences Group SIP Bioreactor Product Offered
11.8.3 Esco Lifesciences Group SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Esco Lifesciences Group Main Business Overview
11.8.5 Esco Lifesciences Group Latest Developments
11.9 Infors AG
11.9.1 Infors AG Company Information
11.9.2 Infors AG SIP Bioreactor Product Offered
11.9.3 Infors AG SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Infors AG Main Business Overview
11.9.5 Infors AG Latest Developments
11.10 KNIKBIO
11.10.1 KNIKBIO Company Information
11.10.2 KNIKBIO SIP Bioreactor Product Offered
11.10.3 KNIKBIO SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 KNIKBIO Main Business Overview
11.10.5 KNIKBIO Latest Developments
11.11 LAMBDA
11.11.1 LAMBDA Company Information
11.11.2 LAMBDA SIP Bioreactor Product Offered
11.11.3 LAMBDA SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 LAMBDA Main Business Overview
11.11.5 LAMBDA Latest Developments
11.12 Solaris Biotech
11.12.1 Solaris Biotech Company Information
11.12.2 Solaris Biotech SIP Bioreactor Product Offered
11.12.3 Solaris Biotech SIP Bioreactor Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Solaris Biotech Main Business Overview
11.12.5 Solaris Biotech Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.